Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive …
Introduction Patients with hematological and advanced solid malignancies have acquired
immune dysfunction, often exacerbated by treatment, posing a significant risk for the …
immune dysfunction, often exacerbated by treatment, posing a significant risk for the …
Access and use of immunoglobulins in secondary supportive cancer care: A systematic literature review
M Counihan, L Cervenakova… - The Journal of …, 2023 - journals.sagepub.com
Background: Immunoglobulin replacement therapy (IgRT) benefits patients with primary
immuno deficiency (PID) originating from the innate or polygenic defects in the immune …
immuno deficiency (PID) originating from the innate or polygenic defects in the immune …
Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set
M Counihan, L Cervenakova… - The Journal of …, 2024 - journals.sagepub.com
Background: Secondary immunodeficiency (SID) disorders are known to occur in patients
with haematological malignancies (HM) due to immunosuppressive treatments. Recurring …
with haematological malignancies (HM) due to immunosuppressive treatments. Recurring …
[HTML][HTML] CLL immune challenges and white paper
N York - clladvocates.net
Cast your minds back to the early stages of the COVID-19 pandemic–to the fear you may
have experienced, the uncertainty and the isolation as you were locked down and were …
have experienced, the uncertainty and the isolation as you were locked down and were …